Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

In cooperation with universities, the Center of Estonian Rural Research and Knowledge (METK) is leading a project aimed at ...

A team of researchers have developed a next-generation biological biosensor capable of detecting trace amounts of explosive ...

Comparing the genomes of snakes with distinct coloration patterns pinpointed the genetic variants that contribute to these ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the effects of specific genetic variants on cancer cell physiology.

Beyond Alzheimer's disease, the findings illuminate fundamental mechanisms of RNA metabolism regulation in neurons. The researchers identified upregulation of transcriptional repressors like YY1 and ...

Bedford ‘s Nicole Steele, a biochemistry and molecular biology major at Clark University, is part of a team working with the ...

Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the protein that forms toxic tangles in Alzheimer's disease.

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common illnesses. So far, only 15 people have received the treatment. But, if all ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...